Finding it hard to breathe when you lay down is medically called orthopnea. Find a list of potential causes to help narrow down your overall risk here.

Madhuri Kukreja spent two and a half years working at a financial services company as an entry level analyst. It was ...

Merck reported Q4 sales of $15.62 billion, surpassing estimates, with EPS at $1.72. Goldman Sachs remains bullish despite a ...

The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...

Financial writer advises caution on investing in Merck & Co., Inc. due to negative sentiment and potential price declines. Click for more on MRK Q4 earnings.

Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...

Goldman Sachs analyst Chris Shibutani adjusted the price target for Merck (NSE:PROR) & Co. Inc. (NYSE:MRK) to $129.00, down from the previous $135.00, while reiterating a Buy rating on the ...

Blockbuster Keytruda makes up nearly half of Merck’s sales. That’s becoming an issue.

The livestock identification market was valued at USD 1.74 billion in 2025 and is projected to reach USD 2.78 billion by 2031 ...

For over-the-counter ibuprofen, you should not take more than 1,200 milligrams per day. Consistently exceeding this amount ...

Nokia (NOK) and AT&T (T) signed a multi-year expansion agreement to upgrade the American company's voice carriage and 5G ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...